Libervant FDA Approval History
Last updated by Judith Stewart, BPharm on May 1, 2024.
FDA Approved: Yes (First approved April 26, 2024)
Brand name: Libervant
Generic name: diazepam
Dosage form: Buccal Film
Company: Aquestive Therapeutics, Inc.
Treatment for: Seizure Clusters
Libervant (diazepam) is a buccal film formulation of the benzodiazepine diazepam that may be given to treat children aged 2 to 5 years with seizure clusters (also known as “acute repetitive seizures”) that are different from their usual seizure pattern.
Development timeline for Libervant
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.